"Lectins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins that share the common characteristic of binding to carbohydrates. Some ANTIBODIES and carbohydrate-metabolizing proteins (ENZYMES) also bind to carbohydrates, however they are not considered lectins. PLANT LECTINS are carbohydrate-binding proteins that have been primarily identified by their hemagglutinating activity (HEMAGGLUTININS). However, a variety of lectins occur in animal species where they serve diverse array of functions through specific carbohydrate recognition.
| Descriptor ID |
D037102
|
| MeSH Number(s) |
D12.776.503
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Lectins".
Below are MeSH descriptors whose meaning is more specific than "Lectins".
This graph shows the total number of publications written about "Lectins" by people in this website by year, and whether "Lectins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 2 | 0 | 2 |
| 2009 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2016 | 5 | 1 | 6 |
| 2017 | 9 | 3 | 12 |
| 2018 | 3 | 3 | 6 |
| 2019 | 3 | 0 | 3 |
| 2020 | 0 | 3 | 3 |
| 2021 | 3 | 2 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Lectins" by people in Profiles.
-
Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies. Nature. 2021 10; 598(7880):342-347.
-
Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins. Front Immunol. 2021; 12:714511.
-
Man-Specific Lectins from Plants, Fungi, Algae and Cyanobacteria, as Potential Blockers for SARS-CoV, MERS-CoV and SARS-CoV-2 (COVID-19) Coronaviruses: Biomedical Perspectives. Cells. 2021 06 28; 10(7).
-
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes. JCI Insight. 2021 06 18; 6(13).
-
Exploring lectin-glycan interactions to combat COVID-19: Lessons acquired from other enveloped viruses. Glycobiology. 2021 05 03; 31(4):358-371.
-
Plasma Lectin Pathway Complement Proteins in Patients With COVID-19 and Renal Disease. Front Immunol. 2021; 12:671052.
-
Algae-Derived Bioactive Molecules for the Potential Treatment of SARS-CoV-2. Molecules. 2021 Apr 08; 26(8).
-
Evidence that Maackia amurensis seed lectin (MASL) exerts pleiotropic actions on oral squamous cells with potential to inhibit SARS-CoV-2 infection and COVID-19 disease progression. Exp Cell Res. 2021 06 01; 403(1):112594.
-
Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics. Pharmacol Rev. 2021 04; 73(2):792-827.
-
Antiviral Cyanometabolites-A Review. Biomolecules. 2021 03 22; 11(3).